Antibiotice S.A. (BVB:ATB)

Romania flag Romania · Delayed Price · Currency is RON
2.425
+0.005 (0.21%)
At close: Jun 27, 2025
-20.49%
Market Cap 1.63B
Revenue (ttm) 666.58M
Net Income (ttm) 97.53M
Shares Out 671.34M
EPS (ttm) 0.15
PE Ratio 16.70
Forward PE n/a
Dividend 0.02 (0.85%)
Ex-Dividend Date Sep 25, 2025
Volume 307,341
Average Volume 270,722
Open 2.405
Previous Close 2.420
Day's Range 2.405 - 2.425
52-Week Range 1.750 - 3.440
Beta 0.12
RSI 64.44
Earnings Date Aug 14, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; and veterinary medicines. Its products are av... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,357
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.

Financial Statements

News

There is no news available yet.